Description

IGF-1 LR3 Research Overview

IGF-1 LR3, also known as Long R3 IGF-1, is a modified form of insulin-like growth factor 1 (IGF-1). It has structural changes intended to alter its interaction with IGF-binding proteins. It is investigated in research involving cell growth, metabolism, and related signaling pathways.

How It Works

IGF-1 activates the IGF-1 receptor, a signaling system involved in cellular growth and metabolism. Downstream pathways include PI3K/Akt and mTOR-related signaling. Modifying this system can affect multiple tissues, making the compound’s biological effects broader than muscle-related research alone.

POTENTIAL RESEARCH INTEREST

  • Cell growth signaling: Studied for interactions with pathways that regulate cell growth and protein synthesis.
  • Metabolic pathways: Relevant to research examining insulin-like growth factor activity and cellular nutrient responses.
  • IGF-binding interactions: Investigated as a modified analog with altered binding characteristics compared with native IGF-1.

These research areas do not establish IGF-1 LR3 as a safe or effective performance-enhancing product.

Side Effects and Safety

IGF signaling can affect glucose regulation and cell proliferation. Potential concerns include hypoglycemia and unwanted tissue-growth effects. Human safety data specific to research-grade IGF-1 LR3 are inadequate, and the long-term implications remain uncertain.

Dosage

No approved dosage is established for IGF-1 LR3 as a research product. Dosing information for medically regulated IGF-1 products should not be transferred to this modified analog.

Handling & Safety

Follow institutional procedures and verify identity, concentration, purity, and storage instructions with the supplier. Treat product specifications as vendor-provided unless independently verified.

Where to Find IGF-1 LR3

IML offers research information and may link to independent vendors. Vendors are responsible for sales, payment processing, product supply, shipping, and related customer support.

Affiliate Disclosure

IML is an informational affiliate directory, not a manufacturer or seller of IGF-1 LR3. Some outbound links may generate referral commissions. Product claims and supply arrangements belong to the independent vendor.

References

  1. Insulin-like growth factors: ligands, binding proteins, and receptors — PubMed
  2. Recombinant IGF-I: past, present and future — PubMed

Additional information

Form

Receptor Grade, Media Grade

Dose

0.2mg, 1mg, 2 x 100mcg (0.1mg) Vials

Sterile-Oil

Sterile Oil Injectable

If you experience injection pain, sterile oil can help ease discomfort by thinning the compound, making injections smoother.

Dose : 64mg per ml/10ml/640mg